The global dermatology CRO market was valued at USD 4.05 billion in 2022 and it is predicted to surpass around USD 7.35 billion by 2032 with a CAGR of 6.14% from 2023 to 2032.
Report Coverage
Report Coverage | Details |
Growth Rate from 2023 to 2032 | CAGR of 6.14% |
Market Revenue by 2032 | USD 7.35 billion |
Revenue Share of Asia Pacific in 2022 | 41.05% |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units)Companies Covered |
Companies Covered | IQVIA; ICON Plc; Charles River Laboratory; Pharmaceutical Product Development, LLC |
Growth Factors
The rise in demand for topical dermatological medications, such as anti-inflammatory agents, anti-infective, local anesthetics, cleansers, and emollients, to treat acne is a major factor driving the market. Furthermore, increased awareness regarding skin diseases, high demand for speedy diagnosis, and an increase in the prevalence of skin cancer and other skin problems are all driving the industry forward.
Factors such as increased investment in R&D programs, a preference for outsourcing tasks due to time and cost constraints, and patent expiration in the dermatology industry are some of the key factors expected to drive the market over the forecast period. Contract research outsourcing collaborations provide cutting-edge services, thus pharmaceutical players and government agencies prefer to delegate projects to dermatology CROs, allowing the market to develop.
By Type Analysis
The clinical segment accounted the dermatology contract research organizations market in 2022 with a revenue share of over 76.05%. The expanding number of biologics, the growing need for personalized medicines and orphan drugs, and the demand for innovative technologies are all contributing to the segment growth.
phase III clinical trials are one of the most expensive stages of a clinical trial, outsourcing them to dermatology CROs helped the clinical segment to gain the largest revenue share in 2020. The preclinical segment is expected to expand at the highest CAGR of 8.53% over the forecast period
By Service Analysis
Clinical monitoring dominated for the largest revenue share of more than 21.05% in 2022 and is expected to maintain its position during the forecast period. This could be due to an increase in the number of clinical trials and the need to monitor those trials, which is driving up demand for services.
dermatology clinical research has been outsourced to CROs for a variety of reasons, including cost-effectiveness and technical knowledge. The use of smart analytics and real-time data capture technologies in the healthcare sector is expected to improve clinical monitoring data.
By Phase Analysis
the phase III segment accounted the market with a revenue share of over 51.04% as phase III clinical studies are the costliest and involve a large number of participants. With 59 novel therapeutic medicines approved by the FDA between 2015 and 2016, the median cost of a single-phase III clinical study is roughly USD 19.0 million.
Phase III also necessitates a larger number of patients and, in many cases, a longer treatment term. The phase II segment held the second-largest revenue share in 2022. This research is split into two parts. The first step involves looking at a variety of doses as well as efficacy trials, and the second half involves deciding on a dose.
By Regional Analysis
Asia Pacific accounted the market with a revenue share of over 41.05% and is expected to grow rapidly in the years to come. This is due to the high prevalence of chronic illnesses, the availability of different populations, the ease with which patients may be recruited and retained, and the implementation of laws that meet acceptance criteria.
Due to the biggest number of trials conducted and outsourced in the area, the market for dermatology CROs in North America captured a significant revenue share in 2022. The growth of this regional market has also been fueled by the increasing government support for R&D activities through grants and money to research institutes and corporations.
Key Players
IQVIA HOLDINGS INC.
Covance Inc.
Pharmaceutical Product Development, LLC (PPD)
Parexel International Corporation
Charles River Laboratories International, Inc.
Icon, Plc
Medidata Solutions, Inc.
Syneos Health
Pharmaron
GVK Biosciences Private Limited
Wuxi AppTec
MEDPACE HOLDINGS, INC.
PRA Health Sciences
CTI Clinical Trial & Consulting
Bioskin
Proinnovera
Biorasi
Javara
TFS
Market Segmentation
By Type
Drug Discovery
Target Validation
Lead Identification
Lead optimization
Preclinical
Clinical
Phase I
Phase II
Phase III
Phase IV
By Service
Project Management/Clinical Supply Management
Data Management
Regulatory/Medical Affairs
Medical Writing
Clinical Monitoring
Quality Management/Assurance
Bio-statistics
Investigator Payments
Laboratory
Patient and Site Recruitment
Technology
Others
By Regional
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Asia Pacific
China
Japan
India
Australia
South Korea
Latin America
Brazil
Mexico
Argentina
Colombia
Chile
Middle East & Africa
South Africa
Saudi Arabia
UAE
Iran
Israel
The Dermatology CRO market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Dermatology CRO market for the base year 2022 and the forecast between 2023 and 2032. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Dermatology CRO market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Dermatology CRO market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Dermatology CRO market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Dermatology CRO capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Dermatology CRO by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Dermatology CRO market. These figures have been provided in terms of both revenue and volume for the period 2022 to 2032. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Dermatology CRO market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Dermatology CRO market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Dermatology CRO industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
Dermatology CRO market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Dermatology CRO market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Dermatology CRO market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Dermatology CRO market. These factors have benefited the growth of the global market for Dermatology CRO. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Dermatology CRO. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Dermatology CRO Market, By Type
7.1. Dermatology CRO Market, by Type, 2023-2032
7.1.1. Drug Discovery
7.1.1.1. Market Revenue and Forecast (2020-2032)
7.1.2. Preclinical
7.1.2.1. Market Revenue and Forecast (2020-2032)
7.1.3. Clinical
7.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 8. Global Dermatology CRO Market, By Services
8.1. Dermatology CRO Market, by Services, 2023-2032
8.1.1. Project Management/Clinical Supply Management
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Data Management
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Regulatory/Medical Affairs
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Medical Writing
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Clinical Monitoring
8.1.5.1. Market Revenue and Forecast (2020-2032)
8.1.6. Quality Management/Assurance
8.1.6.1. Market Revenue and Forecast (2020-2032)
8.1.7. Bio-statistics
8.1.7.1. Market Revenue and Forecast (2020-2032)
8.1.8. Investigator Payments
8.1.8.1. Market Revenue and Forecast (2020-2032)
8.1.9. Laboratory
8.1.9.1. Market Revenue and Forecast (2020-2032)
8.1.10. Patient and Site Recruitment
8.1.10.1. Market Revenue and Forecast (2020-2032)
8.1.11. Technology
8.1.11.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Dermatology CRO Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Type (2020-2032)
9.1.2. Market Revenue and Forecast, by Services (2020-2032)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Type (2020-2032)
9.1.3.2. Market Revenue and Forecast, by Services (2020-2032)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Type (2020-2032)
9.1.4.2. Market Revenue and Forecast, by Services (2020-2032)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Type (2020-2032)
9.2.2. Market Revenue and Forecast, by Services (2020-2032)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Type (2020-2032)
9.2.3.2. Market Revenue and Forecast, by Services (2020-2032)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Type (2020-2032)
9.2.4.2. Market Revenue and Forecast, by Services (2020-2032)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Type (2020-2032)
9.2.5.2. Market Revenue and Forecast, by Services (2020-2032)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Type (2020-2032)
9.2.6.2. Market Revenue and Forecast, by Services (2020-2032)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Type (2020-2032)
9.3.2. Market Revenue and Forecast, by Services (2020-2032)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Type (2020-2032)
9.3.3.2. Market Revenue and Forecast, by Services (2020-2032)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Type (2020-2032)
9.3.4.2. Market Revenue and Forecast, by Services (2020-2032)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Type (2020-2032)
9.3.5.2. Market Revenue and Forecast, by Services (2020-2032)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Type (2020-2032)
9.3.6.2. Market Revenue and Forecast, by Services (2020-2032)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Type (2020-2032)
9.4.2. Market Revenue and Forecast, by Services (2020-2032)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Type (2020-2032)
9.4.3.2. Market Revenue and Forecast, by Services (2020-2032)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Type (2020-2032)
9.4.4.2. Market Revenue and Forecast, by Services (2020-2032)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Type (2020-2032)
9.4.5.2. Market Revenue and Forecast, by Services (2020-2032)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Type (2020-2032)
9.4.6.2. Market Revenue and Forecast, by Services (2020-2032)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Type (2020-2032)
9.5.2. Market Revenue and Forecast, by Services (2020-2032)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Type (2020-2032)
9.5.3.2. Market Revenue and Forecast, by Services (2020-2032)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Type (2020-2032)
9.5.4.2. Market Revenue and Forecast, by Services (2020-2032)
Chapter 10. Company Profiles
10.1. IQVIA HOLDINGS INC.
10.1.1. Company Overview
10.1.2. Type Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Covance Inc.
10.2.1. Company Overview
10.2.2. Type Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Pharmaceutical Product Development, LLC (PPD)
10.3.1. Company Overview
10.3.2. Type Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Parexel International Corporation
10.4.1. Company Overview
10.4.2. Type Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Charles River Laboratories International, Inc.
10.5.1. Company Overview
10.5.2. Type Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Icon, Plc
10.6.1. Company Overview
10.6.2. Type Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Medidata Solutions, Inc.
10.7.1. Company Overview
10.7.2. Type Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Syneos Health
10.8.1. Company Overview
10.8.2. Type Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Pharmaron
10.9.1. Company Overview
10.9.2. Type Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. GVK Biosciences Private Limited
10.10.1. Company Overview
10.10.2. Type Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms